Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
Akoya Biosciences (Nasdaq: AKYA) has scheduled its third quarter 2024 financial results announcement for November 14, 2024, after market close. The company will host a conference call at 5:00 p.m. ET on the same day to discuss the results. Investors must register online to participate in the conference call, with registration recommended at least one day in advance. A live and archived webcast will be available on the company's investor relations website.
Akoya Biosciences (Nasdaq: AKYA) ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2024 per il 14 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 17:00 ET nello stesso giorno per discutere i risultati. Gli investitori devono registrarsi online per partecipare alla conferenza, con registrazione consigliata almeno un giorno prima. Sarà disponibile una webcast dal vivo e registrata sul sito web delle relazioni con gli investitori dell'azienda.
Akoya Biosciences (Nasdaq: AKYA) ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el 14 de noviembre de 2024, después del cierre del mercado. La compañía llevará a cabo una llamada de conferencia a las 5:00 p.m. ET el mismo día para discutir los resultados. Los inversores deben registrarse en línea para participar en la llamada de conferencia, recomendándose registrarse al menos un día antes. Se dispondrá de una transmisión en vivo y grabada en el sitio web de relaciones con inversores de la compañía.
Akoya Biosciences (Nasdaq: AKYA)는 2024년 3분기 재무 결과 발표를 2024년 11월 14일 시장 마감 이후로 예정했습니다. 회사는 같은 날 오후 5시(동부 표준시)에 결과를 논의하기 위한 컨퍼런스 콜을 진행할 것입니다. 투자자들은 컨퍼런스 콜에 참여하기 위해 온라인으로 등록해야 하며, 적어도 하루 전에 등록하는 것이 권장됩니다. 회사의 투자자 관계 웹사이트에서는 실시간 및 녹화된 웹캐스트가 제공될 예정입니다.
Akoya Biosciences (Nasdaq: AKYA) a prévu l'annonce de ses résultats financiers du troisième trimestre 2024 pour le 14 novembre 2024, après la fermeture du marché. L'entreprise animera une conférence téléphonique à 17h00 ET le même jour pour discuter des résultats. Les investisseurs doivent s'inscrire en ligne pour participer à la conférence téléphonique, l'inscription étant recommandée au moins un jour à l'avance. Une webdiffusion en direct et enregistrée sera disponible sur le site web des relations investisseurs de l'entreprise.
Akoya Biosciences (Nasdaq: AKYA) hat die Bekanntgabe der Finanzergebnisse für das dritte Quartal 2024 für den 14. November 2024, nach Marktschluss, angesetzt. Das Unternehmen wird am selben Tag um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu diskutieren. Investoren müssen sich online registrieren, um an der Telefonkonferenz teilzunehmen, wobei eine Registrierung mindestens einen Tag im Voraus empfohlen wird. Eine Live- und aufgezeichnete Webcast wird auf der Website für Investor Relations des Unternehmens verfügbar sein.
- None.
- None.
MARLBOROUGH, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the third quarter of 2024 after the market closes on Thursday, November 14, 2024. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The Company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode™ Panels and PhenoCycler®, PhenoImager® Fusion and PhenoImager HT Instruments. To learn more about Akoya, visit www.akoyabio.com.
FAQ
When will Akoya Biosciences (AKYA) release Q3 2024 earnings?
What time is Akoya Biosciences (AKYA) Q3 2024 earnings call?
How can I access Akoya Biosciences (AKYA) Q3 2024 earnings call?
